Video
Metabolomics and Psoriasis Inflammation: What is the Connection?.
Professor Nicole Ward presents an overview of psoriasis and metabolomics, exploring the question: Do metabolic changes…
Professor Nicole Ward presents an overview of psoriasis and metabolomics, exploring the question: Do metabolic changes…
Watch VideoThe 2024 IPC Think Tank Congress Report provides a comprehensive summary of key topics, including the epidemiology of…
Read MoreNicole Ward explores groundbreaking psoriatic disease research methods published in recent literature. Discover how…
Read MoreThe International Society of Investigative Dermatology (ISID) held its inaugural meeting in Tokyo, Japan, from May 10…
Read MoreThe IPC is a proud supporter of World Psoriasis Day by uniting for action with IFPA to advance care and change the…
Read MoreINTERNATIONAL SOCIETIES FOR INVESTIGATIVE DERMATOLOGY MEETING (ISID) | TOKYO, JAPAN Wednesday, May 10 11:30 - 15:00…
The Psoriasis: from Gene to Clinic International Congress provides a forum for psoriasis experts from around the world…
Read MoreBiologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients…
Read More| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.